Vanguard Group’s DNA X Inc SONM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,389
Closed -$102K 4400
2025
Q3
$102K Buy
+9,389
New +$109K ﹤0.01% 4225
2025
Q2
Sell
-2,807
Closed -$108K 4324
2025
Q1
$108K Hold
2,807
﹤0.01% 4131
2024
Q4
$159K Hold
2,807
﹤0.01% 4126
2024
Q3
$146K Buy
2,807
+1,140
+68% +$71.6K ﹤0.01% 4169
2024
Q2
$300K Buy
1,667
+1
+0.1% +$109 ﹤0.01% 4099
2024
Q1
$183K Buy
1,666
+1
+0.1% +$123 ﹤0.01% 4192
2023
Q4
$220K Buy
1,665
+20
+1% +$2.65K ﹤0.01% 4206
2023
Q3
$198K Hold
1,645
﹤0.01% 4253
2023
Q2
$340K Buy
1,645
+1,418
+625% +$277K ﹤0.01% 4214
2023
Q1
$41.2K Hold
227
﹤0.01% 4489
2022
Q4
$17.3K Buy
227
+1
+0.4% +$82 ﹤0.01% 4501
2022
Q3
$20K Buy
+226
New +$28.1K ﹤0.01% 4590
2022
Q1
Sell
-1,488
Closed -$246K 4639
2021
Q4
$246K Buy
1,488
+113
+8% +$34.3K ﹤0.01% 4538
2021
Q3
$668K Buy
1,375
+47
+4% +$35.7K ﹤0.01% 4331
2021
Q2
$1.33M Buy
1,328
+758
+133% +$824K ﹤0.01% 4090
2021
Q1
$841K Buy
570
+482
+548% +$850K ﹤0.01% 4045
2020
Q4
$114K Hold
88
﹤0.01% 4135
2020
Q3
$122K Sell
88
-48
-35% -$77.2K ﹤0.01% 3999
2020
Q2
$196K Sell
136
-20
-13% -$31.9K ﹤0.01% 3929
2020
Q1
$197K Buy
156
+8
+5% +$38.3K ﹤0.01% 3865
2019
Q4
$968K Buy
148
+13
+10% +$64.1K ﹤0.01% 3650
2019
Q3
$712K Buy
135
+87
+181% +$1.34M ﹤0.01% 3735
2019
Q2
$1.09M Buy
+48
New +$1.22M ﹤0.01% 3648

Other funds holding SONM

Vanguard Group's SONM Position: Q4 2025 in Review

Vanguard Group sold out of DNA X Inc (SONM) in Q4 2025, closing a stake of 9,389 shares — an estimated $102K sold.

Vanguard Group first reported a position in SONM in Q2 2019 and held it in 23 quarters. The position peaked at $1.33M in Q2 2021. 8 funds tracked by Wall St. Rank hold SONM as of Q4 2025.

  • Vanguard Group reported no remaining DNA X Inc position as of Q4 2025 after selling out during the quarter.
  • Vanguard Group sold 9,389 DNA X Inc shares in Q4 2025, an estimated $102K.
  • Vanguard Group first reported a position in DNA X Inc in Q2 2019 and held it in 23 quarters.
  • Vanguard Group's DNA X Inc position peaked at $1.33M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held DNA X Inc as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.